GlaxoSmithKline is sending 340B covered entities refunds for overcharges totaling $100 or more for purchases of two dosage forms of [...] …
Month: August 2023
While two drug manufacturers have recently relaxed or suspended their 340B contract pharmacy restrictions as a result of state laws [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The lead plaintiff in the legal battle that resulted in Medicare proposing an unusual lump sum payback for hospitals’ lost [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Congress should let for-profit hospitals into the 340B drug pricing program as “a long overdue evolutionary step” that will advance [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug makers AbbVie, Bristol Myers Squibb, Janssen, Lilly, and Merck asked a federal district court in South Carolina on Friday [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Changes in the ways Medicare calculates hospitals’ shares of low-income patients that were finalized in a recent payment rule will [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The U.S. Government Accountability Office late last month restated its controversial recommendation that Congress take actions to reduce incentives for [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Hospitals charge, on average, 500% of their acquisition cost for 20 individual medicines that account for the largest share of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drug manufacturer Merck recently loosened its 340B program contract pharmacy restrictions in Louisiana and Arkansas just before Louisiana’s law protecting [...] …